Clinical effect and safety of Feilaoling preparation combined with conventional therapy in treatment of pulmonary tuberculosis

Objective: To observe the clinical effect and safety of Feilaoling preparation which is a traditional Chinese prescription that can improve immune function in 60 cases of untreated pulmonary tuberculosis patients. Methods: Patients with pulmonary tuberculosis (120 cases) were randomly divided into treatment (n = 60) and control (n = 60) groups. The patients in the treatment group were treated with both Feilaoling preparation and conventional chemotherapy, and the patients in the control group were only treated with conventional chemotherapy. The clinical effects, lesions absorption, and side effects of drugs were observed in two groups. Results: The clinical symptoms and signs in treatment group were better than those in control group. Sputum negative conversion rates of two months and six months and cavitates closure have no significant difference between two groups (P > 0.05). But the hemoptysis treatment, lesions absorption improved, incidence rates of liver damage, and white blood reduction in two groups were all effectively changed, the treatment group was better than the control group (P < 0.05). The treatment group has a significant change compared with the control group (P < 0.01) in the incidence rate of severe gastrointestinal discomfort. Conclusion: Feilaoling preparation has a reliable effect on promotion lesions absorption and reducing the side effects of Western anti-tuberculosis, with certain clinical value.